Anacor Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Anacor Pharmaceuticals's estimated annual revenue is currently $10.1M per year.
- Anacor Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Anacor Pharmaceuticals has 50 Employees.
- Anacor Pharmaceuticals grew their employee count by 6% last year.
Anacor Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Payroll/Equity Manager | Reveal Email/Phone |
Anacor Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Anacor Pharmaceuticals?
Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered and is developing five clinical compounds, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis; and GSK 2251052, or GSK '052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis.
keywords:N/AN/A
Total Funding
50
Number of Employees
$10.1M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.8M | 50 | -14% | N/A |
#2 | $5.8M | 50 | 25% | N/A |
#3 | $7.8M | 50 | 4% | N/A |
#4 | $8.3M | 51 | 11% | N/A |
#5 | $6.7M | 51 | 28% | N/A |